Pentagon temporarily rescinds mandatory testosterone testing guidance

The US Pentagon has released comprehensive guidelines mandating testosterone deficiency screenings for active-duty and reserve service members aged 30 and above, beginning immediately. This policy update, announced by Defence Secretary Pete Hegseth in July, aims to bolster military readiness by identifying and addressing hormonal and energy-related concerns.

The guidelines, effective from the moment of issuance on Wednesday, establish standardized screening and treatment protocols for both men and women. Pentagon officials claim the policy seeks to enhance operational efficiency by detecting and managing hormonal and vitality-related problems.

Hegseth's mandate has sparked debate among experts regarding the scientific foundation of such a policy. The US Food and Drug Administration is set to convene an expert panel in mid-September to deliberate on the medical applications of testosterone.

According to the guidelines, men aged 30 and older must undergo mandatory testosterone blood tests. Younger men will only be screened upon request or if healthcare providers detect potential red flags. For women, while routine testosterone blood tests are not mandated, screenings for fatigue and menstrual irregularities associated with hormonal imbalance and conditions such as low-energy availability and relative energy deficiency in sport are recommended.

The document provides clear instructions on the appropriate use of off-label testosterone prescriptions in women, specifically for postmenopausal women experiencing significantly reduced sexual desire. However, medical professionals have expressed apprehension that widespread testosterone testing could result in unnecessary or harmful treatments. They argue that there is insufficient evidence to suggest that mandatory screening for low testosterone among military personnel would significantly improve combat readiness.